Evidence map›Paper›PMID 37288862›Full record

ArticleAnatolian journal of cardiology2023

Neutrophil Gelatinase-Associated Lipocalin Level Can Predict Early Organ Damage in Primary Hypertensive Patients: A Pilot Study.

Serdar Gökhan Nurkoç, Serkan Ünlü, Bayram Şen, Atike Burçin Tefon, Murat Hasanreisoglu, Asife Şahinarslan

Open access · diamondAbstract read
In one paragraph

Article in Anatolian journal of cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Serdar Gökhan NurkoçDepartment of Cardiology, Gazi University Faculty of Medicine, Ankara, Turkey.
Serkan ÜnlüDepartment of Cardiology, Gazi University Faculty of Medicine, Ankara, Turkey.
Bayram ŞenDepartment of Biochemistry, Gazi University Faculty of Medicine, Ankara, Turkey.
Atike Burçin TefonDepartment of Ophthalmology, Gazi University Faculty of Medicine, Ankara, Turkey.
Murat HasanreisogluDepartment of Ophthalmology, Gazi University Faculty of Medicine, Ankara, Turkey.
Asife ŞahinarslanDepartment of Cardiology, Gazi University Faculty of Medicine, Ankara, Turkey.
Gazi University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEarly detection and treatment of complicated arterial hypertension will prevent its effect on the target organs. In line with this purpose, we aimed to reveal the prediction capability of neutrophil gelatinase-associated lipocalin to complicated hypertension.

methodsIn total, 46 patients with hypertension and 21 healthy volunteers were included in the study. Left ventricle morphology and geometry, as systolic and diastolic functions, were analyzed. Global longitudinal strain was measured from recorded apical 3-chamber views. An ophthalmic examination was performed to investigate the presence of retinopathy in individuals with hypertension. In addition, plasma neutrophil gelatinase-associated lipocalin values were evaluated via the method of the enzyme-linked immunosorbent assay.

resultsBoth neutrophil gelatinase-associated lipocalin levels and global longitudinal strain percentages were statistically significant between the groups with diastolic dysfunction and the groups without diastolic dysfunction. Complicated hypertension was detected in 42 patients. Here, it was found that the neutrophil gelatinase-associated lipocalin level of 144.3 ng/mL predicted complicated hypertension with 0.872 sensitivity and 0.65 specificity values.

conclusionAnalyzing neutrophil gelatinase-associated lipocalin levels in patients with hypertension in routine practice can easily and practically detect complicated hypertension patients earlier.

Indexed as

Acute Kidney InjuryHypertensionAcute-Phase ProteinsBiomarkersHumansLipocalin-2LipocalinsPilot ProjectsProto-Oncogene ProteinsAcute-Phase ProteinsBiomarkersLipocalin-2LipocalinsProto-Oncogene Proteins

Identifiers

PMID37288862
PMCPMC10510419
OpenAlexW4379768268

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.